Preservation of canine myocardial high-energy phosphates during low- flow ischemia with modification of hemoglobin-oxygen affinity

Journal of Clinical Investigation

Volumn 103, Issue 5, 1999, Pages 739-746

  Weiss, Robert G ^a   Mejia, Marco A ^a   Kass, David A ^a   DiPaula, Anthony F ^a   Becker, Lewis C ^a   Gerstenblith, Gary ^a   Chacko, V P ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOFIBRATE; CREATINE PHOSPHATE; EFAPROXIRAL; NITRATE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL PH; CORONARY ARTERY BLOOD FLOW; DOG; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE FUNCTION; HEART WORK; HIGH ENERGY PHOSPHATE; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXYGEN AFFINITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0033106385     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6030     Document Type: Article

References (33)

1. Nunnally, R.L. and Bottomley, P.A. 1981. Assessment of pharmacological treatment of myocardial infarction by phosphorus-31 NMR with surface coils. Science. 211:177-180.
2. Deboer, L.W.V., et al. 1983. A flow-and time-dependent index of ischemic injury after experimental coronary occlusion and reperfusion. Proc. Natl. Acad. Sci. USA. 80:5784-5788.
3. 31P NMR spectroscopy of porcine myocardium in vivo. Circ. Res. 64:968-976.
4. Robitaille, P.M., et al. 1989. Transmural metabolite distribution in regional myocardial ischemia as studied with 31P NMR. Magn. Reson. Med. 10:108-118.
5. Weiss, R.G., Bottomley, P.A., Hardy, C.J., and Gerstenblith, G. 1990. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N. Engl. J. Med. 323:1593-1600.
6. Yabe, T., et al. 1994. Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise. Circulation. 89:1709-1716.
7. Shappell, S.D., et al. 1970. Acute change in hemoglobin affinity for oxygen during angina pectoris. N. Engl. J. Med. 282:1219-1224.
8. Kostuk, W.J., Suwa, K., Berstein, E.F., and Sobel, B.E. 1973. Altered hemoglobin oxygen affinity in patients with acute myocardial infarction. Am. J. Cardiol. 31:295-299.
9. Sumimoto, T., et al. 1989. Oxygen delivery, oxygen consumption and hemoglobin-oxygen affinity in acute myocardial infarction. Am. J. Cardiol. 64:975-979.
10. Lichtman, M.A., Cohen, J., Young, J.A., Whitbeck, A.A., and Murphy, M. 1974. The relationships between arterial oxygen flow rate, oxygen binding by hemoglobin, and oxygen utilization after myocardial infarction. J. Clin. Invest 54:501-513.
11. Woodson, R.D., Torrance, J.D., Shappell, T.S., and Lenfant, C. 1970. The effect of cardiac disease on hemoglobin-oxygen binding. J. Clin. Invest. 49:1349-1356.
12. Agostoni, A., et al. 1975. Hemoglobin oxygen affinity in patients with low-output heart failure and cardiogenic shock after acute myocardial infarction. Eur. J. Cardiol. 3:53-58.
13. Metcalfe, J., Dhindsa, D.S., Edwards, M.J., and Mourdjinis, A. 1969. Decreased affinity of blood for oxygen in patients with low-output heart failure. Circ. Res. 25:47-51.
14. Abraham, D.J., Perutz, M.F., and Phillips, S.E. 1983. Physiological and x-ray studies of potential antisickling agents. Proc. Natl. Acad. Sci. USA. 80:324-328.
15. Abraham, D.J., Kennedy, P.E., Mehanna, A.S., Patwas, D.C., and Williams, F.L. 1984. Design, synthesis and testing of potential antisickling agents. Structure-activity relationships of benzyloxy and phenoxy acids. J. Med. Chem. 27:978-981.
16. Lalezari, I., et al. 1990. New effectors of human hemoglobin: structure and function. Biochemistry. 29:1515-1523.
17. Randad, R.S., Mahran, M.A., Mehanna, A.S., and Abraham, D.J. 1991. Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. J. Med. Chem. 34:752-757.
18. Wireko, F.C., Kellog, G.E., and Abraham, D.J. 1991. Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding interaction analysis of novel hemoglobin oxygen effectors. J. Med. Chem. 34:758-767.
19. Abraham, D.J., Wireko, F.C., and Randad, R.S. 1992. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-disubstituted anilino)carbonyl]methyl]phenoxy]-2-methylproprionic acid derivatives that lower the oxygen affity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry. 31:9141-9149.
20. Khandelwal, S.R., et al. 1993. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am. J. Physiol. 265:H1450-H1456.
21. 31P NMR data. Book of abstracts for the Society of Magnetic Resonance in Medcine. Vol. 2. 9:1089. (Abstr.)
22. Flaherty, J.F., et al. 1982. Mechanisms of myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation. 65:561-571.
23. Heymann, M.A., Payne, B.D., Hoffman, J.I., and Rudolph, A.M. 1977. Blood flow measurements with radionuclide labeled particles. Prog. Cardiovasc. Dis. 20:55-79.
24. Lawrence, W.E., Maughan, W.L., and Kass, D.A. 1992. Mechanism of global functional recovery despite sustained postischemic regional stunning. Circulation. 85:816-827
25. DaLuz, P.L., Cavanilles, J.M., Micheals, S., Weil, M.H., and Shubin, H. 1975. Oxygen delivery, anoxic metabolism and hemoglobin oxygen affinity (p50) in patients with acute myocardial infarction and shock. Am. J. Cardiol. 36:148-154.
26. Berman, W., et al. 1987. Systemic oxygen transport in patients with congenital heart disease. Circulation. 75:360-368.
27. Dennis, R.C., et al. 1975. Improved myocardial performance following high 2-3 diphosphoglycerate red cell transfusions. Surgery. 77:741-747.
28. Schrumpf, J.D., Sheps, D.S., Wolfson, S., Aronson, A.L., and Cohen, L.S. 1977. Altered hemoglobin-oxygen affinity with long-term propranolol therapy in patients with coronary artery disease. Am. J. Cardiol. 40:76-82.
29. Oski, F.A., Miller, L.D., Delivoria-Papadopoulos, M., Manchester, J.H., and Shelburne, J.C. 1972. Oxygen affinity in red cells: changes induced in two by propranolol. Science. 175:1372-1373.
30. Gross, G.J. and Hardman, H.F. 1975. Alteration in oxyhemoglobin equilibrium (p50) and myocardial oxygen consumption (MVO2) by nitroglycerin (GTN). J. Pharmacol. Exp. Ther. 193:346-355.
31. Pantely, G.A., Oyama, A.A., Metcalfe, J., Lawson, M.S., and Welch, J.E. 1981. Improvement in the relationship between flow to ischemic myocardium and the extent of necrosis with glycolytic intermediates that decrease blood oxygen affinity in dogs. Circ. Res. 49:395-404.
32. Gross, G.J., Warltier, D.C., and Hardman, H.F. 1977. Effect of ortho-iodo sodium benzoate on hemoglobin-oxygen affinity in normal and ischemic myocardium. J. Pharmacol. Exp. Ther. 203:72-81.
33. Rude, R.E., et al. 1983. Effects of ortho-iodo sodium benzoate on acute myocardial ischemia, hemodynamic function, and infarct size after coronary artery occlusion in dogs. Am. J. Cardiol. 51:1422-1427.